You are here: Industry Insights > COVID-19

News List

Medicago and GSK Announce Positive Phase 3 Efficacy and Safety Results for Adjuvanted Plant-Based COVID-19 Vaccine Candidate AmericanPharmaceuticalReview
December 09, 2021
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline announced positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago's plant-based COVID-19 vaccine candidate in...
Pfizer and BioNTech Provide Update on Omicron Variant AmericanPharmaceuticalReview
December 09, 2021
Pfizer Inc. and BioNTech SE announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from v
Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China prnasia
December 09, 2021
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens...
Chinese mainland reports 44 locally transmitted COVID-19 cases NMPA/Xinhua
December 09, 2021
The Chinese mainland on Tuesday reported 44 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Dec 8.
AHA News: Life Experiences, Outlook Influence How People Are Harmed – Or Helped – By Pandemic Stress Drugs
December 09, 2021
When the COVID-19 pandemic shut down New York City in March 2020, Jose Montanez, like millions of others in the service industry, lost his source of income.
Hyundai Bioscience finds combination therapy effective against Covid-19 Pharmaceutical-Technology
December 09, 2021
Hyundai Bioscience has reported that a combination of the niclosamide-based oral antiviral drug candidate, CP-COV03, with anti-inflammatory therapy, dexamethasone, showed to be effective in people with severe Covid-19 in a study.
Pharmacovigilance Risk Assessment Committee (PRAC) meeting highlights, Dec 2021 EuropeanPharmaceuticalReview
December 08, 2021
EMA’s drug safety committee (PRAC) confirmed the risks of of myocarditis and pericarditis with COVID-19 messenger RNA (mRNA) vaccines.
EMA Expands Authorization for Roche’s Actemra/RoActemra in COVID contractpharma
December 08, 2021
An accelerated assessment by the EMA’s CHMP reviewed results from four studies of Actemra/RoActemra in over 5,500 patients with severe or critical COVID-19.
CHMP recommend approval for Roche’s COVID-19 therapy PharmaTimes
December 08, 2021
According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients.
Maven Clinic Joins The White House Maternal Health Day Of Action, Commits To Expanding COVID-19 Vaccine Education Among Pregnant Population prnewswire
December 08, 2021
Maven Clinic, the world's largest virtual clinic for women's and family health, today announced its participation in the first-ever White House Maternal Health Day of Action.